World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
20910
World Ranking
2202
National Ranking
151

Martin Röcken publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Martin Röcken sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 362 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Martin Röcken D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin Röcken sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2016 - Member of Academia Europaea

Overview

Martin Röcken is affiliated with the University of Tübingen in Germany. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions also in Oncology, Molecular Biology, Dermatology, and Equine studies.

Their work covers several key topics including:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Veterinary Equine Medical Research
  • CAR-T Cell Therapy Research
  • Immune Cell Function and Interaction
  • Immune Cells in Cancer
  • Melanoma and MAPK Pathways

Martin Röcken has published extensively in various venues. The most frequent publication outlets include:

  • Journal of Investigative Dermatology
  • Journal of the European Academy of Dermatology and Venereology
  • Pferdeheilkunde Equine Medicine
  • Theranostics
  • Equine Veterinary Education

Notable recent papers by Martin Röcken are:

  • "Dissecting the treatment-naive ecosystem of human melanoma brain metastasis", 2022, Cell
  • "Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours", 2020, Nature Communications
  • "Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients", 2020, Cancers
  • "European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023", 2023, European Journal of Cancer
  • "European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023", 2023, European Journal of Cancer

Frequent co-authors associated with Martin Röcken include:

  • Thomas Eigentler
  • Lukas Flatz
  • Manfred Kneilling
  • Andrea Forschner
  • Bernd J. Pichler

Martin Röcken has also been recognized as a Member of the Academia Europaea since 2016.

Best Publications

  • T-helper-1-cell cytokines drive cancer into senescence

    Heidi Braumüller;Thomas Wieder;Ellen Brenner;Sonja Aßmann

  • Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

    M.K. Racke;A. Bonomo;D.E. Scott;B. Cannella

  • CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.

    Stefan Zimmermann;Oliver Egeter;Susanne Hausmann;Grayson B. Lipford

  • Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

    Ralph Mocikat;Heidi Braumüller;Heidi Braumüller;Alain Gumy;Oliver Egeter

  • Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease

    Kamran Ghoreschi;Peter Thomas;Susanne Breit;Martin Dugas

  • High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3

    Dominic Francis De Nardo;Larisa I Labzin;Hajime Kono;Reiko Seki

  • Mast Cells Control Neutrophil Recruitment during T Cell–Mediated Delayed-Type Hypersensitivity Reactions through Tumor Necrosis Factor and Macrophage Inflammatory Protein 2

    Tilo Biedermann;Manfred Kneilling;Reinhard Mailhammer;Konrad Maier

  • Angiogenesis drives psoriasis pathogenesis

    Regina Heidenreich;Martin Röcken;Kamran Ghoreschi

  • Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

    Kamran Ghoreschi;Jürgen Brück;Christina Kellerer;Caishu Deng

  • IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.

    Tilo Biedermann;Stephan Zimmermann;Stephan Zimmermann;Hayo Himmelrich;Alain Gumy

  • TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.

    Nele Müller-Hermelink;Heidi Braumüller;Bernd Pichler;Thomas Wieder

  • DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

    Christian Adam;Susan King;Thomas Allgeier;Heidi Braumüller

  • Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study.

    A. Gueniche;B. Knaudt;E. Schuck;T. Volz

  • Immunopathogenesis and role of T cells in psoriasis

    Kamran Ghoreschi;Christina Weigert;Martin Röcken

  • Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging

    York Kamenisch;Maria Fousteri;Jennifer Knoch;Anna-Katharina von Thaler

  • No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.

    Maren Weischer;Andreas Blum;Frank Eberhard;Martin Röcken

  • Infection breaks T-cell tolerance.

    Martin Röcken;Joseph F. Urban;Ethan M. Shevach

  • ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression

    Wolfram Hoetzenecker;Bernd Echtenacher;Emmanuella Guenova;Konrad Hoetzenecker

  • IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

    Emmanuella Guenova;Emmanuella Guenova;Yuliya Skabytska;Wolfram Hoetzenecker;Wolfram Hoetzenecker;Günther Weindl;Günther Weindl

  • In BALB/c Mice, IL-4 Production During the Initial Phase of Infection with Leishmania major Is Necessary and Sufficient to Instruct Th2 Cell Development Resulting in Progressive Disease

    Hayo Himmelrich;Pascal Launois;Ivan Maillard;Tilo Biedermann

  • Nonpathogenic Bacteria Alleviating Atopic Dermatitis Inflammation Induce IL-10-Producing Dendritic Cells and Regulatory Tr1 Cells

    Thomas Volz;Yuliya Skabytska;Emmanuella Guenova;Ko-Ming Chen

Frequent Co-Authors

Kamran Ghoreschi
Kamran Ghoreschi Charité - University Medicine Berlin
Martin Schaller
Martin Schaller University of Tübingen
Claus Garbe
Claus Garbe University of Tübingen
Tilo Biedermann
Tilo Biedermann Technical University of Munich
Thomas Wieder
Thomas Wieder University of Tübingen
Gerd Plewig
Gerd Plewig Ludwig-Maximilians-Universität München
Rupert Handgretinger
Rupert Handgretinger University of Tübingen
Lars Zender
Lars Zender German Cancer Research Center
Klaus Schulze-Osthoff
Klaus Schulze-Osthoff University of Tübingen
Thomas Hartung
Thomas Hartung Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open doors to diverse career opportunities. Many professionals transition into roles that blend immunology knowledge with patient care, making nursing an excellent pathway.

Accelerated programs such as the nurse practitioner accelerated program allow students to fast-track their education and begin practicing within a shorter time frame. These programs are designed for individuals who already hold a bachelor's degree and want to specialize quickly.

If you come from a non-nursing background but want to enter the field, exploring online nursing programs for non nurses can provide a flexible and accessible option. These pathways often accommodate busy schedules and offer comprehensive curricula from foundational to advanced topics.

For those seeking faster completion, 12-month accelerated nursing programs provide an intense, focused curriculum aimed at quickly preparing students for nursing licensure. Alternatively, easy lpn programs to get into can serve as an entry point for nursing careers related to immunology, offering shorter training periods and practical experience.

Choosing the right program depends on your background, career goals, and the time you can commit. These online options make it easier to align your immunology interests with a meaningful healthcare career.

Best Scientists Citing Martin Röcken

Trending Scientists

Recently Published Articles